A randomized, open-label, parallel design study to compare the immunogenicity of simultaneous administration versus sequential administration of quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in the elderly Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis Year: 2017
A randomised controlled trial comparing the immunogenicity, safety and tolerability of a 2012 trivalent seasonal inactivated influenza vaccine administered via a needless injector device versus a traditional pre-filled syringe and needle Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013
Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010
Randomised controlled double blind dose-escalation infant trial of the live-attenuated Mycobacterium tuberculosis vaccine MTBVAC Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019
Immunogenicity and safety of subunit influenza vaccines in pregnant women Source: ERJ Open Res, 4 (2) 00060-2017; 10.1183/23120541.00060-2017 Year: 2018
Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 146s Year: 2002
Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD Source: Virtual Congress 2021 – Pneumonia Year: 2021
Novel intradermal influenza vaccine: phase 3 data in targeted adult populations Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004
RCT Abstract - Ad26.COV2.S immunogenicity in a Phase 2 trial at different booster dose levels and schedule intervals in adults Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021
Atopic disease at 7-years after pertussis vaccination in infancy. Results from a randomized controlled trial of three vaccines Source: Eur Respir J 2001; 18: Suppl. 33, 452s Year: 2001
A randomized, controlled, open-label study to evaluate the efficacy and safety of oral lopinavir-ritonavir in adults hospitalized with COVID-19 virus infection Source: Virtual Congress 2020 – Chinese programme 2020: Part I Year: 2020
Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001
The efficacy and safety of new combined medicinal product in the treatment of influenza: The results of a multicenter randomized comparative clinical trial Source: Annual Congress 2013 –Viral infections: what is new? Year: 2013
Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010 Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Immunological and clinical efficacy of flu vaccination in toddlers Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood Year: 2009
Experimental preclinical study of pandemic H1N1 vaccine "Refluvac" Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010
Is influenza trivalent vaccination effective in lung transplant recipients? Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018
Monitoring the kinetics of a vaccine-induced T-cell response after H1N1 influenza vaccination Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010
The safety and immunogenicity of a conjugated nicotine vaccine: results from a double-blind, placebo-controlled trial in healthy smokers and non-smokers Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004